CIK 0000105770 · Large accelerated filer
WEST PHARMACEUTICAL SERVICES INC
Sign in to watch- Ticker
- WST
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- PA
- Entity type
- operating
- EIN
- 231210010
- Phone
- 6105942900
- Business address
- 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
- Former names
- WEST CO INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,443,749
- in 2 filings, $2.7M under 10b5-1 plans
Net −$5,443,749. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-01 | Favorite Annette F Sr. VP & Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +1,712 | 1,712 | ||
| 2026-03-01 | Campbell Shane Alden SVP, Proprietary Segment | Grant or award · Rst. Stock Unit | +1,131 | 1,131 | ||
| 2026-03-01 | Campbell Shane Alden SVP, Proprietary Segment | Grant or award · Stock Option (Right to Buy) | +2,691 | 2,691 | ||
| 2026-03-01 | McMahon Robert W. SVP & Chief Financial Officer | Grant or award · Rst. Stock Unit | +3,082 | 3,082 | ||
| 2026-03-01 | McMahon Robert W. SVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +7,337 | 7,337 | ||
| 2026-03-01 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Grant or award · Rst. Stock Unit | +437 | 437 | ||
| 2026-03-01 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Grant or award · Stock Option (Right to Buy) | +1,040 | 1,040 | ||
| 2026-03-01 | Winters Chad VP, Chief Accounting Officer | Grant or award · Rst. Stock Unit | +340 | 340 | ||
| 2026-03-01 | Winters Chad VP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +808 | 808 | ||
| 2026-02-20 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Option exercise | +383.38 | 690.78 | ||
| 2026-02-20 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Shares withheld for taxes | −129.55 | $241.12 | $31K | 561.24 |
| 2026-02-20 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Option exercise · Rst. Stock Unit | −383.38 | 383.36 | ||
| 2026-02-20 | Witherspoon Charles VP & Treasurer | Option exercise | +60.22 | 1,429.97 | ||
| 2026-02-20 | Witherspoon Charles VP & Treasurer | Shares withheld for taxes | −22.07 | $241.12 | $5K | 1,407.9 |
| 2026-02-20 | Witherspoon Charles VP & Treasurer | Option exercise · Rst. Stock Unit | −60.22 | 177.64 | ||
| 2026-02-20 | Winters Chad VP, Chief Accounting Officer | Option exercise | +89.33 | 1,552.99 | ||
| 2026-02-20 | Winters Chad VP, Chief Accounting Officer | Shares withheld for taxes | −30.18 | $241.12 | $7K | 1,522.81 |
| 2026-02-20 | Winters Chad VP, Chief Accounting Officer | Option exercise · Rst. Stock Unit | −89.33 | 267.97 | ||
| 2026-02-18 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Option exercise | +82.3 | 335.21 | ||
| 2026-02-18 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Shares withheld for taxes | −27.81 | $248.26 | $7K | 307.4 |
Page 4 of 13 · 257 trades